Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of PM060184 in Advanced Colorectal Cancer After Standard Treatment
2017-000257-39Phase 2Completed
- Sponsor
- PharmaMar
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of plocabulin in colorectal cancer (CRC), sponsored by PharmaMar. Primary endpoint: PFS3. Started Dec 2017; status: completed.
02
Drugs
plocabulin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2017-000257-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000257-39.